Alzheimer's Disease Amyloid beta Peptide 25-35 Inhibits Lipid Peroxidation as a Result of Its Membrane Interactions

By Walter M.F.   Mason P.E.   Mason R.P.  

Biochemical and Biophysical Research Communications, Vol. 233, Iss. 3, 1997-04 ,pp. : 760-764

Elsevier

Access to resources Recommend Favorite

Conformations and Biological Activities of Amyloid Beta Peptide 25-35

By  

Current Protein and Peptide Science, Vol. 11, Iss. 1, 2010-02 ,pp. : 54-67

Bentham Science Publishers

Access to resources Recommend Favorite

Common Core Structure of Amyloid Fibrils by Synchrotron X-ray Diffraction

By Sunde M.   Serpell L.C.   Bartlam M.   Fraser P.E.   Pepys M.B.   Blake C.C.F.  

Journal of Molecular Biology, Vol. 273, Iss. 3, 1997-10 ,pp. : 729-739

Academic Press

Access to resources Recommend Favorite

Effect of Phospholipid Membrane on Conformation of Retro-Sequence Amyloid- beeta-Peptide 35-25 and Normal Amyloid-beeta-Peptide 25-35

By  

Protein and Peptide Letters, Vol. 8, Iss. 5, 2001-10 ,pp. : 395-398

Bentham Science Publishers

Access to resources Recommend Favorite

Computer-aided discovery of novel non-peptide inhibitors against amyloid-beta (Aβ) peptide aggregation for treating Alzheimer's disease

By Zhou Zheng-Li   Ho Yih   Liu Hsuan-Liang   Elumalai Pavadai   Chen Wei-Hsi  

Molecular Simulation, Vol. 41, Iss. 8, 2015-05 ,pp. : 622-632

Taylor & Francis Ltd

Access to resources Recommend Favorite